Here are six things to know:
1. Bioquark will test the theory on 20 clinically dead post-trauma patients.
2. The researchers may also infuse cocktail peptides to the spinal cord as well as perform nerve stimulation techniques.
3. Dr. Calixto Machada, a Cuban neurologist, will head the studies. He has authored many pieces on brain death.
4. The study will combine biologic regenerative medicine tools with central nervous system stimulation medical devices.
5. Bioquark hopes for results as early as two months into the study.
6. The trials will be held at Anupam Hospital in Rudrapur, Uttarakhand, India.
More articles on spine:
Improving spine surgical conversion rates with care coordination
UBMD Physicians Group names Dr. Kevin Gibbons executive director: 5 things to know
Mayo Clinic featured in article about post-spinal surgery complications — 3 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.